{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T10:02:44Z","timestamp":1648634564848},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T00:00:00Z","timestamp":1549670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,9]]},"DOI":"10.1093\/ajhp\/zxy046","type":"journal-article","created":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T03:11:53Z","timestamp":1549681913000},"page":"265-267","source":"Crossref","is-referenced-by-count":1,"title":["Administration of crushed maraviroc via percutaneous gastrostomy tube in a patient with human immunodeficiency virus and progressive multifocal leukoencephalopathy"],"prefix":"10.1093","volume":"76","author":[{"given":"Patricia","family":"Pecora Fulco","sequence":"first","affiliation":[{"name":"Department of Pharmacy Virginia Commonwealth University Health Richmond, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis L","family":"Gatesman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Virginia Commonwealth University Health Richmond, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,2,9]]},"reference":[{"key":"2019061104493936200_CIT0001","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/phar.1921","article-title":"Acute care management of the HIV-infected patient: a report from the HIV Practice and Research Network of the American College of Clinical Pharmacy","volume":"37","author":"Durham","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"8","key":"2019061104493936200_CIT0002","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1002\/phar.1960","article-title":"Decreased absorption of dolutegravir and tenofovir disoproxil fumarate, but not emtricitabine, in an HIV-infected patient following oral and jejunostomy-tube administration","volume":"37","author":"Brooks","year":"2017","journal-title":"Pharmacotherapy"},{"key":"2019061104493936200_CIT0003","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/phar.1835","article-title":"A HAART-breaking review of alternative antiretroviral administration: practical considerations with crushing and enteral tube scenarios","volume":"36","author":"Huesgen","year":"2016","journal-title":"Pharmacotherapy"},{"key":"2019061104493936200_CIT0004","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.2169\/internalmedicine.55.6777","article-title":"Therapeutic drug monitoring of anti-human immunodeficiency virus drugs in a patient with short bowel syndrome","volume":"55","author":"Ikuma","year":"2016","journal-title":"Intern Med"},{"key":"2019061104493936200_CIT0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/2325957417692678","article-title":"Enteral administration of twice-daily dolutegravir and rilpivirine as a part of a triple-therapy regimen in a critically ill patient with HIV","volume":"16","author":"Turley","year":"2017","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"2019061104493936200_CIT0006","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/PHAR.1015","article-title":"Acceptable plasma concentrations of raltegravir and etravirine when administered by gastrostomy tube in a patient with advanced multidrug-resistant human immunodeficiency virus infection","volume":"32","author":"Sandkovsky","year":"2012","journal-title":"Pharmacotherapy"},{"key":"2019061104493936200_CIT0007","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/QAI.0000000000001296","article-title":"Pharmacokinetics of crushed elvitegravir combination tablet given with or without enteral nutrition","volume":"74","author":"Jongbloed-de Hoon","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019061104493936200_CIT0008","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2146\/180090","article-title":"Enhanced HIV viral load suppression with crushed combination tablets containing tenofovir alafenamide and emtricitabine","volume":"75","author":"Fulco","year":"2018","journal-title":"Am J Health-Syst Pharm"},{"key":"2019061104493936200_CIT0009","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.bbmt.2016.08.001","article-title":"A pharmacokinetic and pharmacodynamic study of maraviroc as acute graft-versus-host disease prophylaxis in pediatric allogeneic stem cell transplant recipients with nonmalignant diagnoses","volume":"22","author":"Khandelwal","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"2019061104493936200_CIT0010","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/QAI.0b013e3181ef70fe","article-title":"Maraviroc concentrations in cerebrospinal fluid in HIV-infected patients","volume":"55","author":"Tiraboschi","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019061104493936200_CIT0011","volume-title":"Selzentry (maraviroc) package insert","year":"2017"},{"key":"2019061104493936200_CIT0012","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3851\/IMP2817","article-title":"Switching safely: pharmacokinetics, efficacy and safety of switching efavirenz to maraviroc twice daily in patients on suppressive antiretroviral therapy","volume":"20","author":"Waters","year":"2015","journal-title":"Antivir Ther"},{"key":"2019061104493936200_CIT0013","volume-title":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents"},{"key":"2019061104493936200_CIT0014","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jama.2014.8722","article-title":"Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel","volume":"312","author":"G\u00fcnthard","year":"2014","journal-title":"JAMA"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/76\/5\/265\/28791335\/zxy046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T08:49:44Z","timestamp":1560242984000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/76\/5\/265\/5310469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,9]]},"references-count":14,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,2,9]]},"published-print":{"date-parts":[[2019,2,9]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxy046","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3,1]]},"published":{"date-parts":[[2019,2,9]]}}}